Policy Spotlight

On June 18, 2012, the Senate Health, Education, Labor and Pensions (HELP) Committee and the House Energy and Commerce Committee released a five-year Food and Drug Administration (FDA) user fee reauthorization compromise bill. On Wednesday, June 20, the House of Representatives passed S. 3187, as amended, by voice vote. Senate action is expected as early as Monday on the bill, which will arrive in the Senate in the form of a message between Houses.

View the original site for the complete document.